share_log

Cardio Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director Levy Oded

Cardio Diagnostics | 4: Statement of changes in beneficial ownership of securities

Cardio Diagnostics | 4:持股变动声明
美股SEC公告 ·  2024/04/08 13:03

Moomoo AI 已提取核心信息

On March 31, 2024, Levy Oded, associated with Cardio Diagnostics Holdings Inc. [CDIO], completed a purchase transaction of the company's common stock. A total of 8,803 shares were acquired at a price of $1.42 per share. Following this transaction, Levy Oded directly holds a total of 71,596 shares in Cardio Diagnostics Holdings. The transaction is classified as an exercise or conversion of derivative security, indicating a potential increase in the executive's investment in the company.
On March 31, 2024, Levy Oded, associated with Cardio Diagnostics Holdings Inc. [CDIO], completed a purchase transaction of the company's common stock. A total of 8,803 shares were acquired at a price of $1.42 per share. Following this transaction, Levy Oded directly holds a total of 71,596 shares in Cardio Diagnostics Holdings. The transaction is classified as an exercise or conversion of derivative security, indicating a potential increase in the executive's investment in the company.
2024年3月31日,与Cardio Diagnostics Holdings Inc. [CDIO] 关联的利维·奥德完成了对该公司普通股的收购交易。共收购了8,803股股票,价格为每股1.42美元。在这笔交易之后,Levy Oded直接持有Cardio Diagnostics Holdings总共71,596股股份。该交易被归类为衍生证券的行使或转换,表明该高管对该公司的投资可能增加。
2024年3月31日,与Cardio Diagnostics Holdings Inc. [CDIO] 关联的利维·奥德完成了对该公司普通股的收购交易。共收购了8,803股股票,价格为每股1.42美元。在这笔交易之后,Levy Oded直接持有Cardio Diagnostics Holdings总共71,596股股份。该交易被归类为衍生证券的行使或转换,表明该高管对该公司的投资可能增加。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息